​

STAAR Surgical (STAA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

STAA Stock Forecast

STAAR Surgical (STAA) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $21.95, with a high of $30.75 and a low of $13.00. This represents a 19.36% increase from the last price of $18.39.

$10 $18 $26 $34 $42 $50 High: $30.75 Avg: $21.95 Low: $13 Last Closed Price: $18.39

STAA Stock Rating

STAAR Surgical stock's rating consensus is Hold, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (14.29%), 11 Hold (78.57%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Hold
Total 14 0 1 11 2 Strong Sell Sell Hold Buy Strong Buy

STAA Price Target Upside V Benchmarks

TypeNameUpside
StockSTAAR Surgical19.36%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks25.69%

Price Target Trends

1M3M12M
# Anlaysts159
Avg Price Target$18.00$19.60$23.94
Last Closing Price$18.39$18.39$18.39
Upside/Downside-2.12%6.58%30.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-191-11
Feb, 26-191-11
Jan, 26-19--10
Dec, 25-110--11
Nov, 25-110--11
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 04, 2026Stifel Nicolaus$18.00$19.22-6.35%-2.12%
Feb 09, 2026Stifel Nicolaus$19.00$17.588.08%3.32%
Feb 03, 2026Wedbush$26.00$18.1643.17%41.38%
Jan 16, 2026Morgan Stanley$13.00$20.97-38.01%-29.31%
Jan 15, 2026John YoungCanaccord Genuity$22.00$21.024.66%19.63%
Dec 10, 2025Simran KaurWells Fargo$30.75$25.3821.16%67.21%
Dec 09, 2025John YoungCanaccord Genuity$30.75$25.8918.77%67.21%
Oct 21, 2025John YoungCanaccord Genuity$28.00$25.3210.58%52.26%
Aug 07, 2025Thomas StephanStifel Nicolaus$28.00$26.904.09%52.26%
Jun 11, 2024Ryan ZimmermanBTIG$46.00$38.0720.83%150.14%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 03, 2026WedbushNeutralinitialise
Jan 15, 2026Canaccord GenuityHoldHoldhold
Jan 06, 2026NeedhamHoldHoldhold
Jan 06, 2026BTIGNeutralNeutralhold
Dec 09, 2025Canaccord GenuityHoldHoldhold
Oct 27, 2025Piper SandlerNeutralNeutralhold
Oct 21, 2025Canaccord GenuityHoldHoldhold
Jul 15, 2024Morgan StanleyUnderweightdowngrade
Jun 11, 2024Piper SandlerBuyBuyhold
Apr 09, 2024JefferiesBuyBuyhold

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.52$0.83$0.44$-0.41$-1.62---
Avg Forecast$0.84$1.22$1.04$0.69$0.75$1.07$1.63$2.09
High Forecast$0.86$1.27$1.15$0.75$0.94$1.44$1.81$2.25
Low Forecast$0.81$1.16$0.98$0.65$0.56$0.83$1.45$1.98
Surprise %-38.10%-31.97%-57.69%-159.42%-316.00%---

Revenue Forecast

$200M $290M $380M $470M $560M $650M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$230.47M$284.39M$322.42M$313.90M$239.44M---
Avg Forecast$230.96M$284.45M$322.11M$342.50M$379.40M$428.25M$525.40M$610.45M
High Forecast$235.04M$295.19M$341.03M$344.35M$397.67M$431.61M$531.50M$646.30M
Low Forecast$224.68M$274.29M$308.83M$340.78M$364.71M$424.88M$519.30M$585.28M
Surprise %-0.21%-0.02%0.10%-8.35%-36.89%---

Net Income Forecast

$-100M $-50M $0 $50M $100M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$27.51M$39.66M$21.35M$-20.21M$-80.45M---
Avg Forecast$97.17M$115.79M$21.35M$34.74M$37.12M$56.24M$80.57M$103.30M
High Forecast$116.61M$138.94M$25.62M$37.31M$46.63M$71.23M$89.32M$111.19M
Low Forecast$77.74M$92.63M$17.08M$32.18M$27.62M$41.24M$71.81M$97.77M
Surprise %-71.69%-65.74%--158.17%-316.71%---

STAA Forecast FAQ

Is STAAR Surgical stock a buy?

STAAR Surgical stock has a consensus rating of Hold, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that STAAR Surgical is a neutral investment for most analysts.

What is STAAR Surgical's price target?

STAAR Surgical's price target, set by 14 Wall Street analysts, averages $21.95 over the next 12 months. The price target range spans from $13 at the low end to $30.75 at the high end, suggesting a potential 19.36% change from the previous closing price of $18.39.

How does STAAR Surgical stock forecast compare to its benchmarks?

STAAR Surgical's stock forecast shows a 19.36% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (25.69%).

What is the breakdown of analyst ratings for STAAR Surgical over the past three months?

  • March 2026: 0% Strong Buy, 9.09% Buy, 81.82% Hold, 9.09% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 9.09% Buy, 81.82% Hold, 9.09% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 10.00% Buy, 90.00% Hold, 0% Sell, 0% Strong Sell.

What is STAAR Surgical’s EPS forecast?

STAAR Surgical's average annual EPS forecast for its fiscal year ending in December 2026 is $1.07, marking a -166.05% decrease from the reported $-1.62 in 2025. Estimates for the following years are $1.63 in 2027, and $2.09 in 2028.

What is STAAR Surgical’s revenue forecast?

STAAR Surgical's average annual revenue forecast for its fiscal year ending in December 2026 is $428.25M, reflecting a 78.85% increase from the reported $239.44M in 2025. The forecast for 2027 is $525.4M, and $610.45M for 2028.

What is STAAR Surgical’s net income forecast?

STAAR Surgical's net income forecast for the fiscal year ending in December 2026 stands at $56.24M, representing a -169.90% decrease from the reported $-80.448M in 2025. Projections indicate $80.57M in 2027, and $103.3M in 2028.